Bayesian Capital Management, LP Invitae Corp Transaction History

Bayesian Capital Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$1.71 - $3.61 $183,200 - $386,757	107,135 New	107,135 $199,000
Q1 2020 May 15, 2020	SELL	$7.64 - $27.5 $165,788 - $596,750	-21,700 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$15.02 - $20.57 $325,934 - $446,369	21,700 New	21,700 $350,000
Q2 2019 Aug 13, 2019	SELL	$17.37 - $26.27 $247,713 - $374,636	-14,261 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$10.65 - $25.75 $64,315 - $155,504	-6,039 Reduced 29.75%	14,261 $334,000

Q4 2018 Feb 13, 2019	BUY	$9.26 - $16.38 $52,782 - $93,366	5,700 Added 39.04%	20,300 $225,000
Q3 2018 Nov 14, 2018	BUY	$7.54 - $18.31 $110,084 - $267,326	14,600 New	14,600 $244,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.